"Disease" Definition Is Key Issue In Structure/Function Claims Rule - Henney

The appropriateness of the new definition of "disease" included in FDA's April 1998 proposed rule on structure/function claims is a key issue emerging from the more than 100,000 comments received on the proposal, FDA Commissioner Jane Henney, MD, noted at a House Government Reform Committee hearing March 25. The hearing was called to review FDA's implementation of the Dietary Supplement Health & Education Act, and, in particular, the structure/function claims proposal.